Jeremy Rudnick, M.D
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma (NCT05341947) | Jeremy Rudnick, M.D | 2026-06-01 |
Track Jeremy Rudnick, M.D automatically
Every clearance here is in the API, with alerts when new ones post.